Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence

We aimed to identify aberrantly expressed lncRNA and mRNA expression profiles of dilated cardiomyopathy (DCM) and explore their potential functions. 8 DCM blood samples and paired healthy control blood samples underwent RNA-sequence. Overall design: A prospective case-control study was designed to identify the changes in expression of lncRNA and mRNA. 8 DCM blood samples and paired healthy control blood samples underwent RNA-sequencing, using Illumina HiSeq 4000.